v3.20.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income:    
Revenue
Expenses:    
Research and development 151,864 148,875
General and administrative 1,029,136 1,418,203
Interest 665,232 287,307
Total expenses 1,846,232 1,854,385
Other income 1,250
Net loss $ (1,844,982) $ (1,854,385)
Loss per share:    
Basic and diluted (in dollars per share) $ (0.009) $ (0.026)
Weighted average shares outstanding, basic and diluted (in shares) 202,680,171 70,919,722

Source